                         SEQUENCE LISTING

<110>  Board of Regents, The University of Texas System
 
<120>  METHODS FOR EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES AND USE 
       THEREOF

<130>  UTFC.P1482WO

<150>  US 62/977,672
<151>  2020-02-17

<160>  64    

<170>  PatentIn version 3.5

<210>  1
<211>  429
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  1
gagttccagc tgcagcagtc tggacctgag ctggtgaagc ctggcgcttc agtgaagata       60

tcctgcaagg cttctggtta ctcattcact gactacaaca tgaactgggt gaagcagagc      120

aatggaaaga gccttgagtg gattggagta attaatccta actatggtac tactagctac      180

aatcagaagt tcaagggcaa ggccacattt actgtagacc aatcttccag cacagcctac      240

atgcagctca acagcctgac atctgaggac tctgcagtct attactgtgc aagatccccg      300

gtagaggact actttgacta ctggggccaa ggcaccactc tcacagtctc ctcagccaaa      360

acaacagccc catcggtcta tccactggcc cctgtgtgtg gaggtacaac tggctcctcg      420

gtgactcta                                                              429


<210>  2
<211>  143
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  2

Glu Phe Gln Leu Gln Gln Ser Gly Pro Glu Leu Val Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Ser Phe Thr Asp Tyr 
            20                  25                  30          


Asn Met Asn Trp Val Lys Gln Ser Asn Gly Lys Ser Leu Glu Trp Ile 
        35                  40                  45              


Gly Val Ile Asn Pro Asn Tyr Gly Thr Thr Ser Tyr Asn Gln Lys Phe 
    50                  55                  60                  


Lys Gly Lys Ala Thr Phe Thr Val Asp Gln Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Gln Leu Asn Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Pro Val Glu Asp Tyr Phe Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Thr Leu Thr Val Ser Ser Ala Lys Thr Thr Ala Pro Ser Val Tyr Pro 
        115                 120                 125             


Leu Ala Pro Val Cys Gly Gly Thr Thr Gly Ser Ser Val Thr Leu 
    130                 135                 140             


<210>  3
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  3

Gly Tyr Ser Phe Thr Asp Tyr Asn 
1               5               


<210>  4
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  4
ggttactcat tcactgacta caac                                              24


<210>  5
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  5

Ile Asn Pro Asn Tyr Gly Thr Thr 
1               5               


<210>  6
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  6
attaatccta actatggtac tact                                              24


<210>  7
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  7

Ala Arg Ser Pro Val Glu Asp Tyr Phe Asp Tyr 
1               5                   10      


<210>  8
<211>  33
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  8
gcaagatccc cggtagagga ctactttgac tac                                    33


<210>  9
<211>  380
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  9
gaaaatgtgc tcacccagtc tccagcaatc atgtctgcat ctccagggga aaaggtcacc       60

atgacctgca gggccaggtc aagtgtaagt tccagttact tgcactggta ccagcagaag      120

tcaggtgcct cccccaaact ctggatttat agcacatcca acttggcttc tggagtccct      180

gctcgcttca gtggcagtgg gtctgggacc tcttactctc tcacaatcag cagtgtggag      240

gctgaagatg ctgccactta ttactgccag cagtacagtg gttacccact catcacgttc      300

ggtgctggga ccaagctgga gctgaaacgg gctgatgctg caccaactgt atccatcttc      360

ccaccatcca gtgagcagtt                                                  380


<210>  10
<211>  126
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  10

Glu Asn Val Leu Thr Gln Ser Pro Ala Ile Met Ser Ala Ser Pro Gly 
1               5                   10                  15      


Glu Lys Val Thr Met Thr Cys Arg Ala Arg Ser Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu His Trp Tyr Gln Gln Lys Ser Gly Ala Ser Pro Lys Leu Trp 
        35                  40                  45              


Ile Tyr Ser Thr Ser Asn Leu Ala Ser Gly Val Pro Ala Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Ser Tyr Ser Leu Thr Ile Ser Ser Val Glu 
65                  70                  75                  80  


Ala Glu Asp Ala Ala Thr Tyr Tyr Cys Gln Gln Tyr Ser Gly Tyr Pro 
                85                  90                  95      


Leu Ile Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys Arg Ala Asp 
            100                 105                 110         


Ala Ala Pro Thr Val Ser Ile Phe Pro Pro Ser Ser Glu Gln 
        115                 120                 125     


<210>  11
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  11

Ser Ser Val Ser Ser Ser Tyr 
1               5           


<210>  12
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  12
tcaagtgtaa gttccagtta c                                                 21


<210>  13
<211>  3
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  13

Ser Thr Ser 
1           


<210>  14
<211>  9
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  14
agcacatcc                                                                9


<210>  15
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  15

Gln Gln Tyr Ser Gly Tyr Pro Leu Ile Thr 
1               5                   10  


<210>  16
<211>  30
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  16
cagcagtaca gtggttaccc actcatcacg                                        30


<210>  17
<211>  363
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  17
aggtgaagct gcagcagtca ggacctgagc tggtgaagcc tggggcttca gtgaagatat       60

cctgtaaggc ttctggatac acgttcactg actactacat gaactgggtg aagcagagcc      120

atggaaagag ccttgagtgg attggagata ttaatcctaa caatgatggt actacctact      180

acaaccagaa gttcaagggc aaggccacat tgactgtaga caagtcctcc agcacagcct      240

acatggagct ccgcagcctg acatctgagg actctgcagt ctattactgt gcaagatccc      300

tctacggtag tagctactac tttgactact ggggccaagg caccactctc acagtctcct      360

cag                                                                    363


<210>  18
<211>  120
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  18

Val Lys Leu Gln Gln Ser Gly Pro Glu Leu Val Lys Pro Gly Ala Ser 
1               5                   10                  15      


Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Tyr Tyr 
            20                  25                  30          


Met Asn Trp Val Lys Gln Ser His Gly Lys Ser Leu Glu Trp Ile Gly 
        35                  40                  45              


Asp Ile Asn Pro Asn Asn Asp Gly Thr Thr Tyr Tyr Asn Gln Lys Phe 
    50                  55                  60                  


Lys Gly Lys Ala Thr Leu Thr Val Asp Lys Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Leu Tyr Gly Ser Ser Tyr Tyr Phe Asp Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Thr Leu Thr Val Ser Ser 
        115                 120 


<210>  19
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  19

Gly Tyr Thr Phe Thr Asp Tyr Tyr 
1               5               


<210>  20
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  20
ggatacacgt tcactgacta ctac                                              24


<210>  21
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  21

Ile Asn Pro Asn Asn Asp Gly Thr 
1               5               


<210>  22
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  22
attaatccta acaatgatgg tact                                              24


<210>  23
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  23

Ala Arg Ser Leu Tyr Gly Ser Ser Tyr Tyr Phe Asp Tyr 
1               5                   10              


<210>  24
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  24
gcaagatccc tctacggtag tagctactac tttgactac                              39


<210>  25
<211>  334
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  25
gatattgtga tgacacagtc tcctgcttcc ttagctgtat ctctggggca gagggccacc       60

atctcataca gggccagcaa aagtgtcagt acatctggct atagttatat gcactggaac      120

caacagaaac caggacagcc acccagactc ctcatctatc ttgtatccaa cctagaatct      180

gggatcccag ccaggtttag tggcagtggg tctgggacag acttcaccct caacatccat      240

cctgtggagg aggaggatgc tgcaacctat tactgtcagc aaagtaatga ggacccgtgg      300

acgttcggtg gaggcaccaa gctggaaatc aaac                                  334


<210>  26
<211>  111
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  26

Asp Ile Val Met Thr Gln Ser Pro Ala Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Gln Arg Ala Thr Ile Ser Tyr Arg Ala Ser Lys Ser Val Ser Thr Ser 
            20                  25                  30          


Gly Tyr Ser Tyr Met His Trp Asn Gln Gln Lys Pro Gly Gln Pro Pro 
        35                  40                  45              


Arg Leu Leu Ile Tyr Leu Val Ser Asn Leu Glu Ser Gly Ile Pro Ala 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Asn Ile His 
65                  70                  75                  80  


Pro Val Glu Glu Glu Asp Ala Ala Thr Tyr Tyr Cys Gln Gln Ser Asn 
                85                  90                  95      


Glu Asp Pro Trp Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110     


<210>  27
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  27

Lys Ser Val Ser Thr Ser Gly Tyr Ser Tyr 
1               5                   10  


<210>  28
<211>  30
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  28
aaaagtgtca gtacatctgg ctatagttat                                        30


<210>  29
<211>  3
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  29

Leu Val Ser 
1           


<210>  30
<211>  9
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  30
cttgtatcc                                                                9


<210>  31
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  31

Gln Gln Ser Asn Glu Asp Pro Trp Thr 
1               5                   


<210>  32
<211>  27
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  32
cagcaaagta atgaggaccc gtggacg                                           27


<210>  33
<211>  354
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  33
aggtgcagct gcaggagtct gggggaggct tagtgaagcc tggagggtcc ctgaaactct       60

cctgtgcagc ctctggattc actttcagtg actatggaat gcactgggtt cgtcaggctc      120

cagagaaggg gctggagtgg gttgcataca ttagtagtgg cagtaattcc atctactatg      180

cagacacagt gacgggccga ttcaccatct ccagagacaa tgccaagaac accctgttcc      240

tgcaaatgac cagtctgagg tctgaggaca cggccatgta ttactgtgcc tcgaataatg      300

gttacttcta ctttgactac tggggccaag gcaccactct cacagtctcc tcag            354


<210>  34
<211>  117
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  34

Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly Ser 
1               5                   10                  15      


Leu Lys Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asp Tyr Gly 
            20                  25                  30          


Met His Trp Val Arg Gln Ala Pro Glu Lys Gly Leu Glu Trp Val Ala 
        35                  40                  45              


Tyr Ile Ser Ser Gly Ser Asn Ser Ile Tyr Tyr Ala Asp Thr Val Thr 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Leu Phe Leu 
65                  70                  75                  80  


Gln Met Thr Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys Ala 
                85                  90                  95      


Ser Asn Asn Gly Tyr Phe Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Thr 
            100                 105                 110         


Leu Thr Val Ser Ser 
        115         


<210>  35
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  35

Gly Phe Thr Phe Ser Thr Tyr Gly 
1               5               


<210>  36
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  36
ggattcactt tcagtgacta tgga                                              24


<210>  37
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  37

Ile Ser Ser Gly Ser Asn Ser Ile 
1               5               


<210>  38
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  38
attagtagtg gcagtaattc catc                                              24


<210>  39
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  39

Ala Ser Asn Asn Gly Tyr Phe Tyr Phe Asp Tyr 
1               5                   10      


<210>  40
<211>  33
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  40
gcctcgaata atggttactt ctactttgac tac                                    33


<210>  41
<211>  316
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  41
attgtgatca cccagtctcc agcaatcctg tctgcatctc caggggagaa ggtcacaatg       60

acttgcaggg ccagctcaag tgtaagttac atgcactggt accagcagaa gccaggatcc      120

tcccccaaac cctggattta tgccacatcc aacctggctt ctggagtccc tgctcgcttc      180

agtggcagtg ggtctgggac ctcttactct ctcacagtca gcagagtgga ggctgaagat      240

gctgccactt attactgcca gcagtggagt agtgacccat tcacgttcgg ctcggggaca      300

aagttggaaa taaaac                                                      316


<210>  42
<211>  105
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  42

Ile Val Ile Thr Gln Ser Pro Ala Ile Leu Ser Ala Ser Pro Gly Glu 
1               5                   10                  15      


Lys Val Thr Met Thr Cys Arg Ala Ser Ser Ser Val Ser Tyr Met His 
            20                  25                  30          


Trp Tyr Gln Gln Lys Pro Gly Ser Ser Pro Lys Pro Trp Ile Tyr Ala 
        35                  40                  45              


Thr Ser Asn Leu Ala Ser Gly Val Pro Ala Arg Phe Ser Gly Ser Gly 
    50                  55                  60                  


Ser Gly Thr Ser Tyr Ser Leu Thr Val Ser Arg Val Glu Ala Glu Asp 
65                  70                  75                  80  


Ala Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Ser Asp Pro Phe Thr Phe 
                85                  90                  95      


Gly Ser Gly Thr Lys Leu Glu Ile Lys 
            100                 105 


<210>  43
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  43

Ser Ser Val Ser Tyr 
1               5   


<210>  44
<211>  15
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  44
tcaagtgtaa gttac                                                        15


<210>  45
<211>  3
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  45

Ala Thr Ser 
1           


<210>  46
<211>  9
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  46
gccacatcc                                                                9


<210>  47
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  47

Gln Gln Trp Ser Ser Asp Pro Phe Thr 
1               5                   


<210>  48
<211>  27
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  48
cagcagtgga gtagtgaccc attcacg                                           27


<210>  49
<211>  363
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  49
aggtgaaact gcagcagtca ggacctgagc tggtgaagcc tggggcttca gtgaagatat       60

cctgtaaggc ttctggatac acgttcactg actactacat gaactgggtg aaggagagcc      120

atggaaagag ccttgagtgg attggagata ttaatcctaa caatggtggt tctacctact      180

acaaccagaa gttcaagggc aaggccacat tgactgtaga gaagtcctcc agcacagcct      240

tcatggagct ccgcagcctg acatctgagg actctgcagt ctattactgt gcaagatccc      300

tctacggtag tacctactac tttgactact ggggccaagg cacccctctc acagtctcct      360

cag                                                                    363


<210>  50
<211>  120
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  50

Val Lys Leu Gln Gln Ser Gly Pro Glu Leu Val Lys Pro Gly Ala Ser 
1               5                   10                  15      


Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Tyr Tyr 
            20                  25                  30          


Met Asn Trp Val Lys Glu Ser His Gly Lys Ser Leu Glu Trp Ile Gly 
        35                  40                  45              


Asp Ile Asn Pro Asn Asn Gly Gly Ser Thr Tyr Tyr Asn Gln Lys Phe 
    50                  55                  60                  


Lys Gly Lys Ala Thr Leu Thr Val Glu Lys Ser Ser Ser Thr Ala Phe 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Leu Tyr Gly Ser Thr Tyr Tyr Phe Asp Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Pro Leu Thr Val Ser Ser 
        115                 120 


<210>  51
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  51

Gly Tyr Thr Phe Thr Asp Tyr Tyr 
1               5               


<210>  52
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  52
ggatacacgt tcactgacta ctac                                              24


<210>  53
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  53

Ile Asn Pro Asn Asn Gly Gly Ser 
1               5               


<210>  54
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  54
attaatccta acaatggtgg ttct                                              24


<210>  55
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  55

Ala Arg Ser Leu Tyr Gly Ser Thr Tyr Tyr Phe Asp Tyr 
1               5                   10              


<210>  56
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  56
gcaagatccc tctacggtag tacctactac tttgactac                              39


<210>  57
<211>  334
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  57
gatattgtgc tgacccagtc tccagcttct ttggctgtgt ctctagggca gagggccacc       60

atctcctgca aggccagcca aagtgttgat tatgatggtg atagttatat gaactggtac      120

caacagaagc caggacagcc acccaaactc ctcatctatg ctgcatccaa tctagaatct      180

gggatcccag ccaggtttag tggcagtggg tctgggacag acttcactct caacatccat      240

cctgtggagg aggaggatgc tggaacctat tactgtcagc aaagtaatga cgatccgtgg      300

acgttcggtg gaggcaccaa gctggaaatc aaac                                  334


<210>  58
<211>  111
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  58

Asp Ile Val Leu Thr Gln Ser Pro Ala Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Gln Arg Ala Thr Ile Ser Cys Lys Ala Ser Gln Ser Val Asp Tyr Asp 
            20                  25                  30          


Gly Asp Ser Tyr Met Asn Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro 
        35                  40                  45              


Lys Leu Leu Ile Tyr Ala Ala Ser Asn Leu Glu Ser Gly Ile Pro Ala 
    50                  55                  60                  


Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Asn Ile His 
65                  70                  75                  80  


Pro Val Glu Glu Glu Asp Ala Gly Thr Tyr Tyr Cys Gln Gln Ser Asn 
                85                  90                  95      


Asp Asp Pro Trp Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110     


<210>  59
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  59

Gln Ser Val Asp Tyr Asp Gly Asp Ser Tyr 
1               5                   10  


<210>  60
<211>  30
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  60
caaagtgttg attatgatgg tgatagttat                                        30


<210>  61
<211>  3
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  61

Ala Ala Ser 
1           


<210>  62
<211>  9
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  62
gctgcatcc                                                                9


<210>  63
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  63

Gln Gln Ser Asn Asp Asp Pro Trp Thr 
1               5                   


<210>  64
<211>  27
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  64
cagcaaagta atgacgatcc gtggacg                                           27


